Skip to main content
Atrás
GLPG logo

Galapagos N.V.

Calidad de datos: 100%
GLPG
NASDAQ Healthcare Biotechnology
$30.64
▲ $0.84 (2.82%)
Cap. Mercado: 2.02B
También listada como GLPGF OTC
Rango del Día
$30.15 $30.86
Rango de 52 Semanas
$22.59 $37.78
Volumen
379,756
Promedio 50D / 200D
$33.57 / $32.14
Cierre Anterior
$29.80

Quick Summary

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (631 pares)

Métrica Acción Mediana del Sector
P/E 6.3 0.2
P/B 0.6 3.0
ROE % 10.5 3.5
Net Margin % 28.9 3.8
Rev Growth 5Y % 23.1 9.7
D/E 0.0 0.2

Precio Objetivo de Analistas

Hold
$36.50 +19.1%
Low: $33.00 High: $40.00
EPS Futuro
-$1.65
Ingresos Est.
157.92M

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2030 -$1.61
-$3.22 – -$0.03
 46.99M 1
FY2029 -$1.60
-$3.20 – -$0.03
 37.27M 1
FY2028 -$1.63
-$3.25 – -$0.03
 100.60M 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-23 $1.00 $13.94 +1294.0%
2025-11-05 -$0.20 -$3.59 -1696.4%
2025-07-23 -$0.67 -$1.89 -182.3%
2025-04-23 -$0.23 -$2.47 -973.9%
2025-02-28 -$0.24 $0.39 +263.3%
2024-10-30 -$0.27 -$0.77 -185.2%
2024-09-12 $0.03 $0.14 +450.1%
2024-05-02 -$0.12 $0.39 +425.0%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Puntos Clave

Revenue grew 23.07% annually over 5 years — strong growth
Earnings grew 333.17% over the past year
ROE of 10.47% — decent returns on equity
Net margin of 28.85% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -202.40M

Crecimiento

Revenue Growth (5Y)
23.07%
Revenue (1Y)303.48%
Earnings (1Y)333.17%
FCF Growth (3Y)N/A

Calidad

Return on Equity
10.47%
ROIC10.42%
Net Margin28.85%
Op. Margin40.56%

Seguridad

Debt / Equity
0.00
Current Ratio20.15
Interest Coverage164.04

Valoración

P/E Ratio
6.29
Forward P/EN/A
P/B Ratio0.62
EV/EBITDA4.31
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 303.48% Revenue Growth (3Y) 115.40%
Earnings Growth (1Y) 333.17% Earnings Growth (3Y) 23.12%
Revenue Growth (5Y) 23.07% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.11B Net Income (TTM) 320.90M
ROE 10.47% ROA 9.42%
Gross Margin 93.49% Operating Margin 40.56%
Net Margin 28.85% Free Cash Flow (TTM) -202.40M
ROIC 10.42% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.00 Current Ratio 20.15
Interest Coverage 164.04
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 6.29 Forward P/E N/A
P/B Ratio 0.62 P/S Ratio 1.82
PEG Ratio 0.02 Forward PEG N/A
EV/EBITDA 4.31 Fwd EV/EBITDA 90.65
Forward P/S 12.79 Fwd Earnings Yield N/A
FCF Yield -10.02%
Market Cap 2.02B Enterprise Value 1.94B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.11B 275.65M 239.72M 241.25M 484.85M
Net Income 320.90M 74.08M 211.70M -217.99M -125.42M
EPS (Diluted) 4.85 1.12 -0.06 -3.32 -1.91
Gross Profit 1.04B 240.79M 239.72M 241.25M 483.22M
Operating Income 451.12M -188.34M -88.26M -131.06M -165.60M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.41B 4.14B 4.36B 4.73B 5.19B
Total Liabilities 170.58M 1.24B 1.56B 2.21B 2.55B
Shareholders' Equity 3.23B 2.90B 2.80B 2.53B 2.64B
Total Debt 12.10M 11.72M 9.60M 21.90M 26.86M
Cash & Equivalents 87.83M 64.24M 166.80M 508.12M 2.23B
Current Assets 3.08B 3.34B 3.86B 4.24B 4.86B
Current Liabilities 152.80M 335.08M 428.22M 522.54M 566.47M

Puntuaciones de Estrategias

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Full Throttle
#91 of 148
39

Actividad Reciente

Salió Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entró Defensive Investing (Benjamin Graham)
Mar 24, 2026
Entró Full Throttle
Mar 24, 2026